Subscribe Now Subscribe Today
Science Alert
Curve Top
Journal of Pharmacology and Toxicology
  Year: 2007 | Volume: 2 | Issue: 3 | Page No.: 295-299
DOI: 10.3923/jpt.2007.295.299
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Molecular Modelling Analysis of the Metabolism of Meropenem

Fazlul Huq

Meropenem (MER) is a new carbapenum antibiotic that is highly active in the treatment of a broad range of pathogenic infections including gram-positive and gram-negative bacteria. It is water-soluble and eliminated mainly by renal excretion, through both glomerular filtration and tubular secretion. MER is metabolized into open ring metabolite UK-1a which is also microbiologically active. In healthy volunteers, 70% of the administered dose is excreted as the unchanged drug and 20% as the metabolite UK-1a, in the urine. There is a significant reduction in renal excretory capacity for MER and its metabolite UK-1a in elderly subjects. Molecular modelling analyses based on molecular mechanics, semi-empirical and DFT calculations show that both MER and UK-1a have large LUMO-HOMO energy differences so that they would be kinetically inert. Also, neither MER nor UK-1a is found to abound in electron-deficient regions so that they would not readily react with glutathione and nucleobases in DNA. This may explain why the side-effects from MER-therapy are low.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Fazlul Huq , 2007. Molecular Modelling Analysis of the Metabolism of Meropenem. Journal of Pharmacology and Toxicology, 2: 295-299.

DOI: 10.3923/jpt.2007.295.299






Curve Bottom